These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17357536)

  • 1. Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters.
    Wu CY; Lee WH; Wang JY; Chiang H; Chang JL; Tsai WC; Sheu LF; Jin JS
    Chin J Physiol; 2006 Dec; 49(6):298-304. PubMed ID: 17357536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Wu CY; Lin YF; Wang JY; Yu CP; Sheu LF; Chiang H; Tsai WC; Lee WH
    Dis Markers; 2006; 22(5-6):309-16. PubMed ID: 17264401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclooxygenase-2 (COX-2) in colorectal adenocarcinoma: an immunohistochemical and histopathological study.
    Mahmoud AS; Umair A; Azzeghaiby SN; Alqahtani FH; Hanouneh S; Tarakji B
    Asian Pac J Cancer Prev; 2014; 15(16):6787-90. PubMed ID: 25169526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features.
    Venkatachala S; Rajendran M
    Turk Patoloji Derg; 2017; 33(3):228-234. PubMed ID: 28272681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
    Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
    Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters.
    Tsai WC; Chao YC; Sheu LF; Chang JL; Nieh S; Jin JS
    Dis Markers; 2007; 23(3):153-60. PubMed ID: 17473384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
    Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
    Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphB1 is underexpressed in poorly differentiated colorectal cancers.
    Sheng Z; Wang J; Dong Y; Ma H; Zhou H; Sugimura H; Lu G; Zhou X
    Pathobiology; 2008; 75(5):274-80. PubMed ID: 18931529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased matriptase/HAI-1 ratio in advanced colorectal adenocarcinoma of Chinese patients.
    Tsai WC; Sheu LF; Chao YC; Chen A; Chiang H; Jin JS
    Chin J Physiol; 2007 Oct; 50(5):225-31. PubMed ID: 18274158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters.
    Lee YY; Yu CP; Lin CK; Nieh S; Hsu KF; Chiang H; Jin JS
    Dis Markers; 2009; 26(1):9-18. PubMed ID: 19242064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
    Lam AK; Ong K; Ho YH
    Hum Pathol; 2008 Apr; 39(4):599-604. PubMed ID: 18284933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.
    Negi RR; Rana SV; Gupta V; Gupta R; Chadha VD; Prasad KK; Dhawan DK
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1675-1681. PubMed ID: 31244287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of tissue-specific proteolytic enzymes in adenomas containing foci of early carcinoma: correlations with cathepsin D expression and other malignant features.
    Kunimura T; Inagaki T; Wada M; Ushio J; Sato K; Enosawa T; Nakashima M; Kato H; Hayashi R; Saitou K; Morohoshi T
    Int J Gastrointest Cancer; 2003; 33(2-3):149-54. PubMed ID: 14716064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas.
    Wendum D; Svrcek M; Rigau V; Boëlle PY; Sebbagh N; Parc R; Masliah J; Trugnan G; Fléjou JF
    Mod Pathol; 2003 Feb; 16(2):130-6. PubMed ID: 12591965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic importance of COX-2 expression in patients with colorectal cancer.
    Yamac D; Celenkoglu G; Coskun U; Akyurek N; Akcali Z; Dursun A; Koybasioglu F
    Pathol Res Pract; 2005; 201(7):497-502. PubMed ID: 16164044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2 protein in colorectal carcinomas.
    Joo YE; Kim HS; Min SW; Lee WS; Park CH; Park CS; Choi SK; Rew JS; Kim SJ
    Int J Gastrointest Cancer; 2002; 31(1-3):147-54. PubMed ID: 12622426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
    Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related alteration in the association of microsatellite instability with absent hMLH1 expression and histological types of colorectal carcinoma.
    Arai T; Sugai T; Kasahara I; Sawabe M; Honma N; Aida J; Nakamura S; Takubo K
    Pathol Int; 2006 Oct; 56(10):597-603. PubMed ID: 16984616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinoma.
    Almhanna K; El-Rayes B; Sethi S; Dyson G; Heilbrun L; Philip PA; Sarkar F
    Anticancer Res; 2012 Aug; 32(8):3559-63. PubMed ID: 22843946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.